Agala, Ponciana A.
HRN: 23-84-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/13/2023
10/20/2023
IVT
4.5g
Q6
Cellulitis; Hepatic Enceph
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes